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Alterations in cAMP signaling are thought to contribute to neurocognitive and neuropsychiatric disorders. Members of the cAMP-
specific phosphodiesterase 4 (PDE4) family, which contains25 different isoforms, play a key role in determining spatial cAMP degra-
dation so as toorchestrate compartmentalized cAMPsignaling in cells. Each isoformbinds to adifferent set of protein complexes through
its unique N-terminal domain, thereby leading to targeted degradation of cAMP in specific intracellular compartments. However, the
functional role of specific compartmentalized PDE4 isoforms has not been examined in vivo. Here, we show that increasing protein levels
of the PDE4A5 isoform in mouse hippocampal excitatory neurons impairs a long-lasting form of hippocampal synaptic plasticity and
attenuates hippocampus-dependent long-termmemorieswithout affecting anxiety. In contrast, viral expressionof a truncated versionof
PDE4A5,which lacks theuniqueN-terminal targetingdomain, doesnot affect long-termmemory. Further, overexpressionof thePDE4A1
isoform, which targets a different subset of signalosomes, leaves memory undisturbed. Fluorescence resonance energy transfer sensor-
based cAMPmeasurements reveal that the full-length PDE4A5, in contrast to the truncated form, hampers forskolin-mediated increases
in neuronal cAMP levels. Our study indicates that the unique N-terminal localization domain of PDE4A5 is essential for the targeting of
specific cAMP-dependent signaling underlying synaptic plasticity andmemory. The development of compounds to disrupt the compart-
mentalization of individual PDE4 isoforms by targeting their unique N-terminal domains may provide a fruitful approach to prevent
cognitive deficits in neuropsychiatric and neurocognitive disorders that are associated with alterations in cAMP signaling.
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Introduction
The cAMP signaling pathway plays an essential role in synaptic
plasticity andmemory (Havekes and Abel, 2009). Local degrada-
tion of cAMP within specific intracellular compartments is pre-
cisely orchestrated by cAMP-degrading phosphodiesterases
(PDEs; Houslay, 2010; Mika et al., 2012). Isoforms of the PDE4
subfamily have a prominent role in regulating cAMP signaling in
the mammalian brain (Houslay and Adams, 2003; O’Donnell
and Zhang, 2004; Sanderson and Sher, 2013), in Drosophila
(Conti and Jin, 1999), and in the Aplysia nervous system (Park et
al., 2005). Although the catalytic cAMP-degrading domain of the
PDE4 isoforms is highly conserved, all of the25 described iso-
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forms have a unique N-terminal domain that targets each iso-
form to specific intracellular compartments, where it binds to a
unique set of protein complexes (Houslay, 2010). Pharmacolog-
ical suppression of PDE4 activity promotes synaptic plasticity
and memory (Randt et al., 1982; Barad et al., 1998; Rutten et al.,
2009; Werenicz et al., 2012). The PDE4 selective inhibitor, rolip-
ram, prevents memory deficits associated with sleep loss (Vecsey
et al., 2009), traumatic brain injury (Titus et al., 2013), aging
(Wimmer et al., 2012), muscarinic or NMDA receptor blockade
(Egawa et al., 1997; Zhang and O’Donnell, 2000; Wiescholleck
and Manahan-Vaughan, 2012), and mouse models of Alzhei-
mer’s disease (Gong et al., 2004; Reneerkens et al., 2009; Richter
et al., 2013).However, the clinical use of broad PDE4 inhibitors is
limited due to undesirable side effects, including emesis and di-
arrhea (Zeller et al., 1984; Bertolino et al., 1988; Spina, 2008). To
circumvent these issues, which compromise the clinical use of
pan-PDE4 inhibitors, studies are needed to identify which PDE4
isoforms target signaling complexes critical for cognitive pro-
cesses and then to exploit such data to develop isoform-specific
inhibitor approaches.
The PDE4 family is encoded by four genes (PDE4A–PDE4D;
Houslay, 2010). PDE4B knock-out mice perform normally in
hippocampus-dependent learning paradigms (Siuciak et al.,
2008), but display an anxiogenic-like phenotype (Zhang et al.,
2008), a phenotype also observed in mice lacking PDE4A iso-
forms (Hansen et al., 2014). Importantly, recent work revealed
that the PDE4A family is not involved in emesis (Hansen et al.,
2014), in contrast to the PDE4D subfamily (Robichaud et al.,
2002). Mice lacking all PDE4D isoforms display either memory
enhancements or impairments, depending on the task used (Rut-
ten et al., 2008; Li et al., 2011). Although these mutant mouse
models provide insight into the role of PDE4 families in plasticity
and memory, they lack the resolution needed to identify which
individual isoforms orchestrate the observed behavioral and cog-
nitive phenotypes.
The importance of studying individual PDE family members
is underscored by the complex regulation of isoform expression,
which includes multiple promoters, alternative mRNA splicing,
and alternative translational initiation sequences (Houslay et al.,
2007). Expression levels of individual PDE4 isoforms are altered
in traumatic brain injury (Oliva et al., 2012), autism spectrum
disorders, schizophrenia, and bipolar disorder (Braun et al.,
2007; Fatemi et al., 2008a,b) by electroconvulsive shock delivery
and treatment with antidepressants (Takahashi et al., 1999; D’Sa
et al., 2005). Changes in cerebellar expression levels of PDE4A4,
the human ortholog of rodent PDE4A5, are observed in patients
with autism or bipolar disorder (Braun et al., 2007; Fatemi et al.,
2008a). Further, PDE4A4/5 levels are upregulated in the lung
tissue of patients with chronic obstructive pulmonary disease
(COPD; Barber et al., 2004). Interestingly, COPD patients fre-
quently experience sleep loss (Crinion and McNicholas, 2014), a
condition that elevates PDE4A5 protein expression in the mouse
hippocampus without affecting levels of other PDE4 isoforms
(Vecsey et al., 2009). Although these findings suggest that mem-
ory impairments may be associated with altered PDE4A4/5 ex-
pression, it is unclear whether PDE4A4/5 in healthy conditions
targets signaling mechanisms that are critical for memory. In the
present study, we used a viral approach to increase the mouse
PDE4A5protein levels selectively in hippocampal excitatory neu-
rons in vivo to assess the impact of elevated PDE4A5 expression
on hippocampal synaptic plasticity and memory.
Materials andMethods
Subjects. C57BL/6J male mice (2–3 months of age) were obtained from
The Jackson Laboratory at 6 weeks of age and housed in groups of four
with littermates on a 12 h light/dark schedule with lights on at 7:00 A.M.
[zeitgeber time 0 (ZT0)]. Mice had food and water available ad libitum.
Mice underwent surgery at 8–12 weeks of age, were individually housed
for 5 d to recover from surgery, and then were pair housed throughout
the experiment. For all behavioral experiments,mice were handled in the
experimental room for 5 d for 1 min/d. All experiments were conducted
according to National Institutes of Health (NIH) Guide for the Care and
Use of Laboratory Animals andwere approved by the Institutional Animal
Care and Use Committee of the University of Pennsylvania.
Viral injections. The adeno-associated viruses (AAVs) were injected
using a nanofil 33 ga beveled needles (WPI) attached to a 10l Hamilton
syringe controlled by a microsyringe pump (model UMP3, WPI) at the
following sites (anteroposterior, 1.9 mm from bregma; dorsoventral,
1.5 mm from bregma; and 1.5 mm below bregma), as described previ-
ously (Havekes et al., 2014). The needle was slowly lowered to the target
site over the course of 3 min and remained at the target site for 1 min
before the beginning of the injection (0.2 l/min). Approximately 1 l
(corrected for genome copy number between constructs) was injected
per hippocampus. After the injection, the needle remained at the target
site for 1 min and then was slowly removed over a 5 min period.
DNA manipulation and virus constructs. Full-length rat PDE4A5 and
mouse PDE4A1 constructs were based on GenBank accession numbers
L27057.1 and M26715. The truncated PDE4A5 that lacks the first
303 bp encoding the isoform-unique N-terminal domain (referred to as
PDE4A54; Bolger et al., 2003) was generated using standard PCR
cloning procedures and the Stratagene PfuUltra High-Fidelity DNA
polymerase. pAAV9-CaMKII0.4-PDE4A5-VSV, pAAV9-CaMKII0.4-
PDE4A54-HA, pAAV9-CaMKII0.4-PDE4A1-HA, and pAAV9-
CaMKII0.4-eGFP were produced through standard methods and
packaged by the Penn Vector Core at the University of Pennsylvania.
Titers ranged from 1.06 1013 to 2.02 1013 genome copy numbers. A
0.4 kb CaMKII promoter fragment (Dittgen et al., 2004) was used to
drive expression selectively in excitatory neurons.
Biochemistry. ELISA-based assay kits (ENZO Life Sciences) were used
tomeasure cAMP content following themanufacturer instructions. PDE
activity assays andWestern blots were conducted as described previously
(Vecsey et al., 2009). For all other protein analyses, tissue lysates were
prepared in Tris 50 mM, pH 9, sodium deoxycholate 1%, sodium fluor-
ide 50 mM, activated sodium vanadate 20 M, EDTA 20 M, and
-glycerophosphate 40 M. Protease inhibitors (Roche) and phospha-
tase inhibitors (Thermo Scientific) were added to the freshly prepared
buffer just before tissue lysates. Samples were centrifuged for 10 min at
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13,000 g at 4°C, and supernatant was collected. Protein concentration
of the samples was measured using the Bradford method. LDS sample
buffer (Nupage, Invitrogen) including -mercaptoethanol was added,
and samples were boiled for 5 min before loading on Criterion TGX
18-well 4–20% gels (Bio-Rad). After electrophoresis, proteins were
transferred to PVDFmembrane followed by blocking for 1 h in 5%milk
in TBST. After blocking, membranes were incubated in 5%milk or BSA
with one of the following antibodies: GAPDH (1:1000; K1511, Santa
Cruz Biotechnology); PDE4A (1:1000; Vecsey et al., 2009); PDE4A5 (1:
1000; Vecsey et al., 2009); HA tag (1:1000; catalog #1867423, Roche); and
vesicular stomatitis virus (VSV) tag (1:3000; catalog #1874, Abcam). Af-
ter incubation with the primary antibodies, membranes were incubated
with HRP-conjugated secondary antibodies for 1 h at room temperature
(1:1000, mouse secondary antibody, sc-2318, Santa Cruz Biotechnology;
1:5000, rabbit secondary antibody, sc-2030, Santa Cruz Biotechnology;
rat secondary antibody, sc-2032, 1:1000, Santa Cruz Biotechnology). The
immunoreactive bands were captured on autoradiography film (Kodak)
and analyzed using ImageJ (NIH).
Immunohistochemistry. Immunohistochemistry was conducted as de-
scribed previously (Isiegas et al., 2008). The following antibodies or com-
binations of antibodies were used: PDE4A5 (1:200; Vecsey et al., 2009);
HA tag (1:200; catalog #1867423, Roche); VSV tag (1:2000; catalog
#1874, Abcam); GFAP-Alexa Fluor 488 (1:300; catalog #43202, Milli-
pore); followed by the appropriate Alexa Fluor-conjugated secondary
antibodies (1:1000; Invitrogen) for 1 h at room temperature. Imageswere
captured using a Leica SP8 confocal microscope. Immunolabeling for
cAMP was conducted using cAMP antibodies (1:200; catalog #07-1497,
Millipore) in combination with the DAB procedure (Havekes et al.,
2007). Optical density measurements in the corpus callosum were used
to correct for background labeling. DAB images were captured using a
Fisher Scientific light microscope, and optical density measurements
were conducted using ImageJ.
Behavioral assays. The object–place recognition task, fear-conditioning
task, open field task, and zeromaze task were conducted as described previ-
ously (Tretter et al., 2009; Oliveira et al., 2010; Havekes et al., 2012b, 2014).
Training and testing was conducted between ZT0 and ZT4.
Cell culture studies. Neurons (100,000/ml of C57BL/6J mouse hip-
pocampus) were plated in a 24-well dish with coated coverslips. A week
later, we transduced the neurons with AAV vectors expressing VSV-
tagged PDE4A5 (PDE4A5-VSVg) and HA-tagged PDE4A5 N-terminal
truncated mutant (PDE4A5delta4-HA). At 7 d post-transduction, the
neuronal cells were fixed with 4% paraformaldehyde in PBS and incu-
bated with anti-VSV (ab1874, Abcam) and anti-HA (ab130275, Abcam)
antibodies for immunofluorescence analysis. The neuron samples were
visualized with secondary antibodies conjugated with Alexa Fluor 488
and 568 dyes (ThermoFisher Scientific) using a fluorescence imaging
microscope with GFP- and RFP-selective filter sets.
Electrophysiology. Field recordings in hippocampal slices were con-
ducted as previously described (Havekes et al., 2012b).
Fluorescence resonance energy transfer sensor imaging. cAMP was mea-
sured using the ICUE3 biosensor, as described previously (DiPilato and
Zhang, 2009). Primary rat hippocampal cultures were obtained as de-
scribed previously (Neves et al., 2008). Primary hippocampal cultures
(8–12 d in vitro) were transfected using Lipofectamine 2000 (Life Tech-
nologies) with pICUE3 (provided by Jin Zhang, Johns Hopkins Univer-
sity, Baltimore, MD) and mCherry alone, or pPDE4A5-full-mCherry or
pPDE4A5-truncated-mCherry. Twenty-four hours later, neurons were
preincubated for 60 min at 37°C with nifedipine (Sigma-Aldrich) and
tetrodotoxin (Tocris Bioscience) to eliminate any calcium or
depolarization-induced signaling. Neurons were then transferred to an
imaging chamber maintained at 32°C and continually perfused with 1
HBSS (Life Technologies) containing 25 mM HEPES buffer (Life Tech-
nologies), 10 mM glucose, and 0.5 mM Trolox (Sigma-Aldrich). Multiple
ICUE3- and mCherry-expressing neurons were selected. Transfected
neurons were imaged every 60 s on an inverted Axio-Observer Z1micro-
scope (Zeiss) with an automated stage using AxioVision 4.8 software
using a Plan-Apochromat 40/1.3 oil-objective and a QuantEM
electron-multiplying charge-coupled device camera (Photometrics), il-
luminated by a Colibri controlled LED system (Zeiss). At each time
point, images were acquired from the Cerulean and fluorescence reso-
nance energy transfer (FRET) channels with the following settings: for
Cerulean: excitation (ex), LED 455 nm; emission (em), 475/40 nm; for
FRET: ex, LED 455 nm; em, 535/25 nm. The time course of the experi-
ment contained the following three phases: 5–7 min baseline; 25 min of
50 M Forskolin (FK; Tocris Bioscience); followed by 10 min of 100 M
3-isobutyl-1-methylxantine (IBMX; Tocris Bioscience) to saturate the
cAMP response. Images were converted into grayscale values, and the
dendritic fluorescent intensities were measured with ImageJ after back-
ground correction. The ratio of Cerulean and FRET was calculated for
each time point.
Statistical analyses.Data analysis was performed using SPSS version 20
(SPSS). Data were analyzed using one-way or two-way ANOVAs (in
some cases with repeated measures as the within-subject variable),
independent-sample t tests, paired t tests, or one-way ANOVAs com-
bined with Tukey post hoc tests. Differences were considered statistically
significant at p 0.05. All data are plotted as the mean SEM.
Results
Overexpression of PDE4A5 in hippocampal excitatory
neurons increases PDE4 activity and reduces cAMP levels
Virally induced PDE4A5 expression was observed in excitatory
neurons throughout the hippocampus (Fig. 1A–E). Double-
labeling studies using GFAP as a marker for astrocytes suggested
that expression was restricted to neurons (Fig. 1F–H). Biochem-
ical analyses confirmed the virally induced increase in PDE4A5
protein levels in hippocampal lysates (eGFP, n 4; PDE4A5, n
4; t(7)  6.84; p  0.001; Fig. 1I) and elevated PDE4 activity
(eGFP, n 10; PDE4A5, n 9; t(17) 13.67; p 0.0001; Fig. 1J),
with a lack of a change in non-PDE4 cAMP hydrolyzing activity
(t(17)0.77; p 0.453; Fig. 1J). Increased hippocampal PDE4
activity caused reduced cAMP levels in the hippocampus (eGFP,
n 5; PDE4A5, n 5; t(7) 3.94; p 0.0056; Fig. 2A), but not
in either the prefrontal cortex or cerebellum (t(7)  0.35, p 
0.732, and t(8)  1.16, p  0.279, respectively; Fig. 2A). A re-
duction in cAMP immunoreactivity was evident in all three ma-
jor hippocampal regions (eGFP, n  8; PDE4A5, n  8; CA1,
t(14) 2.10, p 0.029; CA3, t(14) 2.50, p 0.026; DG, t(14)
2.51, p  0.025; Fig. 2B,C), but not in the amygdala (AMY;
t(14)0.33; p 0.372; Fig. 2B,C). Together, these data indicate
that the overexpression of PDE4A5 in hippocampal excitatory
neurons increases PDE4 activity and reduces cAMP levels in the
hippocampus without affecting cAMP content in other brain
regions.
Elevated hippocampal PDE4A5 levels attenuate cAMP-
dependent synaptic plasticity
Initial electrophysiological characterization of synaptic transmis-
sion in the Schaffer collateral–CA1 pathway involved measuring
basal synaptic transmission and paired-pulse facilitation (PPF),
an index of short-term plasticity. Increased PDE4A5 protein lev-
els did not alter basal synaptic transmission (eGFP, n  8;
PDE4A5, n  8; t(14)  1.37; p  0.192; Fig. 3A) or PPF (eGFP,
n  9; PDE4A5, n  9; ANOVA, effect of virus, F(1,16)  0.024,
p  0.879; Fig. 3B). Maximum fEPSP slopes were not signifi-
cantly different between groups (eGFP, n  9, 10.56  1.12
mV/ms; PDE4A5, n 9,10.45 1.55mV/ms; t(12) 0.06; p
0.949). Bath application of FK activates adenylyl cyclases, leading
to increased intracellular cAMP levels and synaptic potentiation
(Vecsey et al., 2009; Havekes et al., 2012b; Park et al., 2014).
PDE4A5 overexpression reduces the synaptic potentiation fol-
lowing application of forskolin (50 M) with a significant reduc-
tion in themean fEPSP slope over the last 20min of the recording
(eGFP, 175.7 17.7%; PDE4A5, 109.4 21.0%; t(11) 2.42; p
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0.035; Fig. 3C). This finding suggests that cAMP-dependent syn-
aptic plasticity in the hippocampus is impaired by elevating
PDE4A5 levels. In future studies, it will be interesting to deter-
minewhether PDE4A5 overexpression also reproduces deficits in
other long-lasting forms of LTP known to be attenuated by sleep
deprivation, such as LTP induced by spaced four-train or theta
burst stimulation (Vecsey et al., 2009; Prince et al., 2014).
Increasing PDE4A5 in the hippocampus attenuates the
formation of long-term context–shock associations
We first assessed whether selective overexpression of PDE4A5 in
hippocampal neurons attenuates long-term memory formation
of context–shock associations. Increased PDE4A5 protein in the
hippocampus did not affect freezing levels during training
(eGFP, n 14; PDE4A5, n 14; preshock, t(26) 0.83, p 0.40;
postshock, t(26)  0.20, p  0.84; Fig.
4A) but resulted in reduced freezing levels
during re-exposure to the training context
24 h after conditioning (eGFP, 41.9 
2.7%; PDE4A5, 29.3 3.0%; t(26) 3.06,
p  0.005; Fig. 4A). Because short-term
contextual fear memories do not rely on
cAMP signaling (Bourtchouladze et al.,
1998), we hypothesized that PDE4A5
overexpression would not affect short-
term memory formation for context–
shock associations. Consistent with this,
increasing PDE4A5 protein levels did
not alter freezing levels during training
(eGFP, n  9; PDE4A5, n  9; preshock,
t(16)0.18, p 0.85; postshock, t(16)
0.87, p 0.39; Fig. 4B), or the findings of
a retention test 1 h after training (t(16) 
0.48, p  0.85, p  0.64; Fig. 4B). Thus,
increasing PDE4A5 protein levels specifi-
cally affects the consolidation of long-
term contextual fear memories.
Tone-cued fear conditioning is a task
in which rodents associate a tone [condi-
tioned stimulus (CS)] with a mild electri-
cal shock (unconditioned stimulus), a
process that requires the amygdala rather
than the hippocampus (LeDoux, 2000).
Mice (eGFP, n  12; PDE4A5, n  13)
overexpressing PDE4A5 expressed similar
freezing levels during the conditioning
(preshock, t(23)  0.80, p  0.43; CS;
t(23)  1.06, p  0.30; postshock, t(23) 
0.54, p  0.60; Fig. 4C). Twenty-four
hours after training, mice were exposed to
a novel context and re-exposed to the CS.
Both groups showed similar freezing lev-
els during exposure to the novel context
(t(23)  0.66, p  0.51; Fig. 4C), and
exposure to the CS (t(23) 0.26, p 0.80;
Fig. 4C). Thus, tone-cued fear condition-
ing is not affected by the overexpression of
PDE4A5 in hippocampal neurons.
PDE4A5 differs from other isoforms
by virtue of a 102 aa unique N-terminal
targeting domain (Beard et al., 2002;
Bolger et al., 2003). To determine
whether PDE4A5 requires this domain
to target signaling complexes critical for the formation of con-
text–shock associations, we engineered a truncated version of
PDE4A54 that lacks the first 303 bp encoding the PDE4A54
(Bolger et al., 2003) and virally expressed this N-terminally
truncated species in hippocampal neurons. In contrast to full-
length PDE4A5, this truncated version failed to impair long-
term memory for context–shock associations (t(15)  1.10,
p  0.28; Fig. 4D). To further assess the specificity of the
PDE4A5-mediated long-term memory deficit, we replicated
the experiment, but now increased the levels of the PDE4A1
isoform. This short PDE4A isoform is exclusively membrane
associated, with a major fraction of PDE4A1 found compart-
mentalized to the Golgi (Shakur et al., 1995; Pooley et al.,
1997). In contrast to the increased expression of PDE4A5,
elevated protein levels ofPDE4A1 inhippocampalneuronsdidnot
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Figure 1. Overexpression of PDE4A5 in hippocampal excitatory neurons increases PDE4A5 protein levels and PDE4 activity. A,
Mice were bilaterally injected with AAV9-CaMKII-eGFP or AAV9-CaMKII-PDE4A5-VSV into the hippocampus. B, Viral PDE4A5
protein expressionwas restricted to the hippocampus. C–E, Viral expression of PDE4A5was observed in all threemajor hippocam-
pal subregions. F–H, Transgene expressionwas not observed in hippocampal astrocytes (PDE4A5-VSV, red; GFAP, green; bottom).
I, A representative immunoblot for PDE4A5 protein levels. Viral overexpression of PDE4A5 leads to significantly higher PDE4A5
protein levels inhippocampal lysates. J, OverexpressionofPDE4A5 significantly increasesPDE4activitywithout affectingnon-PDE4
activity. All error bars denote SEM. ***p 0.001, ****p 0.0001.
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affect long-term memory formations (t(13)1.25, p 0.23; Fig.
4D). Together, these findings indicate that the unique N-terminal
region of PDE4A5 confers the functional targeting of a core catalytic
PDE4A module to a critical signaling complex in hippocampal ex-
citatory neurons involved in regulating the formation of long-term
contextual fear memories where it determines spatially localized
cAMP degradation.
Overexpression of PDE4A5 in hippocampal excitatory
neurons attenuates the consolidation of long-term
object–place memories
To examine the impact of PDE4A5 overexpression on a nonaver-
sive hippocampus-dependent task, we turned to the object–loca-
tion memory paradigm in which mice have to learn and
remember the location of individual objects (Oliveira et al., 2010;
Havekes et al., 2014). Mice expressing eGFP (n 14) or PDE4A5
(n  15) gradually reduced object exploration levels across the
training sessions, indicating that animals acquired the locations
of the individual objects (eGFP: session 1, 18.9 1.3 s; session 2,
13.0  1.2 s; session 3, 13.2  2.0 s; PDE4A5: session 1, 24.1 
2.2 s; session 2, 18.4 1.8 s; session 3, 13.7 1.7 s; ANOVA effect
of session, F(2,54)  34.9, p  0.0001). Overall, PDE4A5 mice
showed slightly elevated exploration levels (ANOVA, effect of
virus, F(1,27) 4.756, p 0.038).During the test session 24 h after
training, eGFP mice preferentially explored the displaced ob-
ject, indicating that they successfully remembered the previ-
ous location of the individual objects. In contrast, mice
overexpressing PDE4A5 explored all objects to a similar ex-
tent, which is indicative of a poor memory for the original
object locations (eGFP, 49.8  5.2%; PDE4A5, 31.3  3.1%;
t(27)  3.11; p  0.004; Fig. 4E).
The novel object recognition task is based on the natural ten-
dency of rodents to explore novel objects (Ennaceur and Dela-
cour, 1988; Oliveira et al., 2010). Because the training conditions
we use do not require an intact hippocampus (Oliveira et al.,
2010), we anticipated that object–identity memories should not
be affected by the overexpression of PDE4A5 in hippocampal
neurons. During training, eGFP (n  8) and PDE4A5 (n  10)
mice showed no preference for either object (Fig. 4F), although
the total object exploration levels were elevated in the mice over-
expressing PDE4A5 (eGFP, 20.9 1.1%; PDE4A5, 31.3 3.1%;
t(16)  3.923; p  0.005). During the test session 24 h after
training, both groups preferentially explored the novel object,
indicating that they successfully discriminated the novel ob-
ject from the familiar object (ANOVA, effect of object prefer-
ence: F(1,16)  18.623, p  0.001; ANOVA, effect of virus:
F(1,16)  0.274, p  0.608; interaction effect, F(1,16)  0.013,
p  0.912; Fig. 4F ).
To determine whether N-terminal-mediated targeting of
PDE4A5 was essential for the ability of PDE4A5 to regulate the
formation of object–place memories, we again expressed the
N-terminal truncated formof PDE4A5, referred to as PDE4A54,
in hippocampal neurons and trained mice in the object–location
memory task. During the retention test and then some 24 h after
training, both groups preferentially explored the displaced object
(eGFP, n  8; PDE4A54, n  9; ANOVA, effect of object:
F(1,15)  25.217, p  0.0001; ANOVA, effect of virus: F(1,15) 
0.36, p  0.852; Fig. 4G). Next, we assessed whether elevated
expression of the short PDE4A isoform PDE4A1, which targets
theGolgi (Shakur et al., 1995; Pooley et al., 1997), would similarly
attenuate the formation of object–location memories. In line
with our fear-conditioning results, increased expression of
Figure 2. Overexpression of PDE4A5 in hippocampal excitatory neurons reduces cAMP levels in the hippocampus.A, Viral expression of PDE4A5 reduces cAMP levels in the hippocampus, but not
in the prefrontal cortex or cerebellum.B, C, Representative cAMP immunoreactivity images inmice expressing eGFP or overexpressing PDE4A5. Note the reduction in cAMP immunoreactivity in the
major hippocampal subregions, but not in the amygdala. All error bars denote SEM. *p 0.05, **p 0.01.
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PDE4A1 did not affect the formation of object–location memo-
ries (eGFP, n  8; PDE4A1, n  7; ANOVA, effect of object:
F(1,13)  63.271, p  0.0001; ANOVA, effect of virus: F(1,13) 
0.277, p  0.608; Fig. 4G). The latter finding suggests that
PDE4A1 does not target protein complexes critical for the forma-
tion of object–locationmemories. These data imply that PDE4A5
negatively impacts the formation of object–locationmemories by
involving protein–protein interactions that target its unique
N-terminal domain.
In a final set of behavioral studies, we determined whether the
memory deficits associated with PDE4A5 expression could be a
result of behavioral abnormalities unrelated to memory forma-
tion. Hippocampal overexpression of PDE4A5 does not affect
explorative behavior or anxiety levels in, respectively, an open
field (eGFP, n 6; PDE4A5, n 8; t(12)1.44; p 0.175; Fig.
4H) and a zero maze (eGFP, n  9; PDE4A5, n  10; t(17) 
0.653; p  0.523; Fig. 4I). Thus, our behavioral studies indicate
that the N-terminal targeting domain of PDE4A5 plays an essen-
tial role in the targeting of cAMP signaling that is critical for
long-term memory formation.
Full-length PDE4A5 but not truncated PDE4A5 attenuates
forskolin-mediated FRET cAMP responses
Because our behavioral studies suggested that the N-terminal
domain plays an essential role in the compartmentalization of
PDE4A5, we measured cAMP responses
using the ICUE3 biosensor in hip-
pocampal neurons expressing a control
vector, full-length PDE4A5, or the
N-terminal domain lacking PDE4A54.
Baseline FRET responses were not af-
fected by the overexpression of either
construct (ANOVA, effect of construct:
F(2,44)  1.984, p  0.198; Fig. 5A,B).
The expression of PDE4A5, but not
PDE4A54, attenuated the forskolin-
mediated FRET response (ANOVA, effect
of construct: F(2,44) 11.991, p 0.0001;
PDE4A5 vs control, Tukey test, p 0.001;
PDE4A5 vs PDE4A54, Tukey test, p 
0.001; Fig. 5A,B). Consecutive bath appli-
cation with the PDE inhibitor IBMX nor-
malized the FRET responses (ANOVA,
effect of construct, F(2,44)  0.295, p 
0.746; Fig. 5A,B), indicating that the de-
crease in FRET response due to the over-
expression of PDE4A5 was not a result of
nonspecific alterations in PDE/cAMP sig-
naling. Together, these data indicate that
theN-terminal domain of PDE4A5plays a
critical role in the localization of PDE4A5
to specific intracellular domains, where it
hampers local cAMP-dependent pro-
cesses critical for synaptic plasticity and
memory.
The N-terminal domain of PDE4A5
plays an essential role in the
compartmentalization of PDE isoforms
Our behavioral data suggest that the
N-terminal domain of PDE4A5 plays an
essential role in the compartmentaliza-
tion of the PDE4A5 isoform to cAMP-
containing complexes that are critical for learning and memory.
Therefore, we virally expressed full-length and truncated N-
terminal-lacking PDE4A5 in cultured hippocampal neurons to
compare the intracellular distribution of these isoforms. We
found that the focus of full-length PDE4A5 immunofluorescence
in the cultured neurons is in both a discrete perinuclear area and
in dendritic compartments (Fig. 6, left). In contrast, truncated
PDE4A5 lacking the N-terminal domain unique for this isoform
was located predominantly in the perinuclear region (Fig. 6,mid-
dle). These findings confirm previous work (Houslay et al., 1998;
Huston et al., 2000) highlighting the importance of isoform
unique N-terminal domains in determining the intracellular dis-
tribution of PDE4A enzymes.
Discussion
Phosphodiesterases play an essential role in orchestrating the
compartmentalized degradation of cAMP, leading to local
changes in cAMP signaling in specific subcellular domains in the
cell (Houslay, 2010). This is in part achieved by isoform-specific
N-terminal domains that bind to specific localized protein com-
plexes, which enable individual PDE isoforms to target local
cAMP signaling and thereby to regulate a unique set ofmolecular
processes (Houslay, 2010). The PDE4A5 isoform has a unique
102 aa N-terminal region involved in its intracellular targeting
(Beard et al., 2002; Bolger et al., 2003). Using a viral approach, we
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show that increased selective expression of PDE4A5 in hip-
pocampal excitatory neurons attenuates a cAMP-dependent
form of synaptic plasticity in hippocampal area CA1, reduces
forskolin-mediated increases in cAMP content in cultured hip-
pocampal neurons, and impairs long-term memory formation
specifically in learning tasks that require the hippocampus. Fur-
thermore, to assess the role of theN-terminal domain of PDE4A5
in compartmentalizing and targeting cAMP-dependent signaling
complexes that are critical for memory storage, we replicated the
biochemical and behavioral studies using an N-terminal-lacking
truncated version of the same protein. In contrast to the observa-
tions with full-length PDE4A5, the expression of the N-terminal
truncatedPDE4A5 construct does not attenuate forskolin-mediated
alterations in cAMP responses in cultured neurons and does not
affect hippocampus-dependent forms ofmemory, but does alter the
intracellular distribution of this isoform.
Our overexpression studies with full-length PDE4A5 and
PDE4A1 as well as truncated PDE4A5 emphasize that increases
in the protein levels of specific PDE4 isoforms initiates the
decrease in cAMP levels in specific neuronal compartments
rather than causing a global nonspecific decrease in cAMP
throughout the cell. Our overexpression studies suggest that
the common domains shared by the different PDE4A iso-
forms, including the catalytic domain and the conserved reg-
ulatory regions 1 and 2 (UCR1 and UCR2), do not likely
contribute to the hippocampus-dependent cognitive deficits
associated with PDE4A5 overexpression. The lack of an impact
of the N-terminal-lacking PDE4A5 isoform at the behavioral
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level is not likely to be explained by a reduction in the efficacy
of the truncated isoform to degrade cAMP, as we previously
shown that the loss of the isoform-specific N-terminal domain
leads to an increase rather than a decrease in catalytic activity
(Beard et al., 2002).
Our findings also reveal the importance of the isoform-
specific N-terminal domain for targeting individual PDE4 iso-
forms to cAMP signaling that is critical for cognitive processes,
and confirms and expands on previous in vitrowork showing that
truncation of the N-terminal region of PDE4A5 alters its mem-
brane association and localization at the cell margin (Huston et
al., 2000; Beard et al., 2002; Bolger et al., 2003; Houslay, 2010). At
the membrane, PDE4 isoforms can interact with molecular ele-
ments that are critical for learning and memory, such as  arres-
tins (Li et al., 2009). The unique N-terminal domain of PDE4A5
also allows for association with certain SH3 domain-containing
proteins, such as certainmembers of the src tyrosyl kinase family,
including Src, Fyn, and Lyn (Beard et al., 1999, 2002), and recent
work indicates that Fyn inhibition reverses memory deficits in
mouse models for Alzheimer’s disease (Kaufman et al., 2015).
PDE4A5 also interacts with Disrupted-in-Schizophrenia 1
(DISC1;Murdoch et al., 2007), amajor risk factor for schizophre-
0.95
1.00
1.05
1.15
1.10
1.20
0 5 10 15 20 25 30 35 40
FSK IBMX
0.90
1.00
1.10
1.05
0.95
1.15
1.20
FSK IBMXVEV
mCherry/IUC3 
PDE4A5-mCherry/IUC3 
PDE4A5Δ4-mCherry/IUC3 
Av
er
ag
ed
 N
or
m
al
iz
ed
 F
R
ET
/C
FP
 ra
tio
s
A
Av
er
ag
ed
 N
or
m
al
iz
ed
 F
R
ET
/C
FP
 ra
tio
s
B
***
Figure 5. Full-length but not truncated PDE4A5 attenuates FK-mediated cAMP responses assessed by a FRET indicator.A, FRET cAMP responsesweremeasured in cultured hippocampal neurons
expressing a control construct, PDE4A5, or truncated N-terminal domain-lacking PDE4A54 after consecutive bath application with the adenylate cyclase activator FK and phosphodiesterase
inhibitor IBMX. Forskolin treatment significantly elevated cAMP levels in control neurons and neurons expressing PDE4A54,whereas the cAMP responsewas attenuated in neurons overexpressing
full-length PDE4A5.B, Average FRET sensor responses for the different treatment conditions. Baseline FRET responses were not affected by the overexpression of either construct. The expression of
PDE4A5, but not PDE4A54, attenuated the forskolin-mediated FRET response. Consecutive bath applications with the PDE inhibitor IBMX normalized the FRET responses. CT 20 cells from three
preparations; PDE4A5 11 cells from three preparations; PDE4A54 14 cells from three preparations. All error bars denote SEM. ***p 0.001.
Figure 6. Loss of the isoform-unique N-terminal domain alters the compartmentalization of PDE4A5 in hippocampal neurons. Full-length PDE4A5 is compartmentalized to both a discrete
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nia and other psychiatric diseases, such as bipolar disorder and
depression (Porteous and Millar, 2006). Therefore, the misregu-
lation of DISC1-related signaling mechanisms may contribute to
the endophenotypes associated with the overexpression of
PDE4A5. The N-terminal domain of PDE4A5 also binds the im-
munophilin XAP2 (also called AIP and ARA9; Bolger et al.,
2003), although, to our knowledge, no studies have examined the
role of XAP2 in learning and memory. Deletion of the unique
part of the N-terminal domain also disrupts the focus of PDE4A5
localization within ruffles at the cell margin (Beard et al., 2002).
Because membrane ruffles play an essential role in cell motility
and spine dynamics and through the remodeling of the actin
cytoskeleton (Chhabra and Higgs, 2007; Honkura et al., 2008),
one additional mechanism through which PDE4A5 could affect
memory formation is by negatively impacting cAMP-dependent
signaling mechanisms that modulate actin dynamics. Future
studies including coimmunoprecipitation and colocalization ex-
periments with the N-terminal domain-binding proteins will
have to define whether these candidate mechanisms indeed con-
tribute to the plasticity deficits andmemory impairments associ-
ated with elevated expression of this isoform.
Sleep deprivation negatively impacts cognitive processes, par-
ticularly those that require the hippocampus (Havekes et al.,
2012a; Abel et al., 2013; Kreutzmann et al., 2015). We previously
found that a single brief period of sleep deprivation elevated
PDE4 activity and reduced cAMP levels in the hippocampus.
These changes were accompanied by a specific increase in
PDE4A5 protein expression without affecting the protein levels
of other PDE4 isoforms, such as PDE4B, PDE4D3, and PDE4D5
(Vecsey et al., 2009). Thememory deficits associatedwith a single
5 h period of sleep deprivation could be prevented by pharmaco-
logical inhibition of the PDE4 family (Vecsey et al., 2009) and by
transiently increasing cAMP levels selectively in hippocampal
neurons (Havekes et al., 2014). Despite these observations, it
remains to be defined whether the increase in PDE4A5 function
in the hippocampus was causally related to thememory and plas-
ticity impairments associated with sleep loss. In our current
study, we observed that increasing hippocampal PDE4A5 levels
impairs long-term memory formation in contextual fear condi-
tioning and object–place recognition tasks (Fig. 4). In both learn-
ing paradigms, the formation of long-term memories critically
depends on proper hippocampal function (LeDoux, 2000; Ol-
iveira et al., 2010), and the observed impairments in both tasks
mimic those observed with sleep deprivation (Graves et al., 2003;
Vecsey et al., 2009; Hagewoud et al., 2010; Florian et al., 2011;
Havekes et al., 2012a, 2014; Abel et al., 2013). Using electrophys-
iological recordings, we show that increasing PDE4A5 protein
levels impairs forskolin-induced synaptic plasticity (Fig. 3), a def-
icit that also occurs after 5 h of sleep deprivation (Vecsey et al.,
2009). In summary, this work reveals that the elevated expression
of the PDE4A5 isoform in hippocampal neurons is sufficient to
mimic electrophysiological and cognitive phenotypes associated
with sleep loss.
To our knowledge, this work is the first to define the function
of the PDE4A5 isoform and protein domains in hippocampal
function. From a broader perspective, our work will help to de-
fine the contribution of individual PDE isoforms to the endophe-
notypes of neurocognitive and neuropsychiatric disorders that
are accompanied by altered PDE signaling and facilitate the de-
velopment of novel therapeutic strategies based on the targeting
of specific domains of individual PDE isoforms. Related to this
notion, there is now a wealth of evidence consistent with the idea
that the evolutionary conserved diversity of N-terminal regions
that define specific PDE4 isoforms is related to their recruitment
to specific signaling complexes (Houslay, 2010). We, and others,
have demonstrated that such interactions can be disrupted using
cell-permeable peptides and also that such species can phenocopy
dominant-negative approaches (Smith et al., 2007; Serrels et al.,
2010;Martin et al., 2014). Indeed, an engineered peptide disrupt-
ing PDE4D–HSP20 interactions shows in vivo efficacy in amouse
model of pressure overload-mediated hypertrophy (Martin et al.,
2014). The ability to refine such disruptor peptides for in vivo use
could be facilitated through the use of nuclear magnetic reso-
nance to uncover their structure (Smith et al., 2007), together
with the incorporation of non-native amino acids and the
addition of lipid species to facilitate cell entry together with trun-
cation and modification to generate peptidomimetic species.
Identification of the functional anchor species for PDE4A5 in this
scenario would then take developments to a level where high-
throughput screening for small-molecule, drug-like disruptor
species of PDE4A5 and its functional anchor becomes a realistic
approach. Additionally, high content screens for compounds that
dislocate PDE4A5 from its relevant compartment in cells would
provide anothermeans of such compounds. The aimwould be to
uncover small peptides and peptidomimetics of small molecules
that enter the brain and dislocate PDE4A5 from the functionally
relevant anchor protein/signaling complex to recapitulate the
phenotype we describe in these studies.
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